Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15(7):387–404

Article  CAS  PubMed  Google Scholar 

Adams D, Polydefkis M, Gonzalez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada Lopez IA, Dispenzieri A, Quan D, Conceicao IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Plante-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T, OLESG Patisiran Global (2021) Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol 20(1):49–59

Article  CAS  PubMed  Google Scholar 

Coelho T, Maia LF, da Silva AM, Cruz MW, Plante-Bordeneuve V, Suhr OB, Conceicao I, Schmidt HH, Trigo P, Kelly JW, Labaudiniere R, Chan J, Packman J, Grogan DR (2013) Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol 260(11):2802–2814

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brannagan TH, Wang AK, Coelho T, Waddington Cruz M, Polydefkis MJ, Dyck PJ, Plante-Bordeneuve V, Berk JL, Barroso F, Merlini G, Conceicao I, Hughes SG, Kwoh J, Jung SW, Guthrie S, Pollock M, Benson MD, Gertz M, N-TO-LE Investigators (2020) Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. Eur J Neurol 27(8):1374–1381

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adams D, Tournev IL, Taylor MS, Coelho T, Plante-Bordeneuve V, Berk JL, Gonzalez-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M, Collaborators H-A (2023) Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial. Amyloid 30(1):1–9

Article  PubMed  Google Scholar 

Ando Y, Adams D, Benson MD, Berk JL, Plante-Bordeneuve V, Coelho T, Conceicao I, Ericzon BG, Obici L, Rapezzi C, Sekijima Y, Ueda M, Palladini G, Merlini G (2022) Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis. Amyloid 29(3):143–155

Article  CAS  PubMed  Google Scholar 

Yang NC, Lee MJ, Chao CC, Chuang YT, Lin WM, Chang MF, Hsieh PC, Kan HW, Lin YH, Yang CC, Chiu MJ, Liou HH, Hsieh ST (2010) Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser. Neurology 75(6):532–538

Article  CAS  PubMed  Google Scholar 

Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y (2017) Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology 88(23):2192–2197

Article  CAS  PubMed  Google Scholar 

Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y (2019) Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Amyloid 26(sup1):79–80

Article  PubMed  Google Scholar 

Ebenezer GJ, Liu Y, Judge DP, Cunningham K, Truelove S, Carter ND, Sebastian B, Byrnes K, Polydefkis M (2017) Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. Ann Neurol 82(1):44–56

Article  CAS  PubMed  Google Scholar 

Chao CC, Hsueh HW, Kan HW, Liao CH, Jiang HH, Chiang H, Lin WM, Yeh TY, Lin YH, Cheng YY, Hsieh ST (2019) Skin nerve pathology: Biomarkers of premanifest and manifest amyloid neuropathy. Ann Neurol 85(4):560–573

Article  CAS  PubMed  Google Scholar 

Freeman R, Gonzalez-Duarte A, Barroso F, Campagnolo M, Rajan S, Garcia J, Kim JY, Wang N, Orellana L, Gibbons C (2022) Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages. Ann Clin Transl Neurol 9(9):1370–1383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leonardi L, Adam C, Beaudonnet G, Beauvais D, Cauquil C, Not A, Morassi O, Benmalek A, Trassard O, Echaniz-Laguna A, Adams D, Labeyrie C (2022) Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis. Eur J Neurol 29(5):1477–1487

Article  PubMed  Google Scholar 

Leonardi L, Galosi E, Vanoli F, Fasolino A, Di Pietro G, Luigetti M, Sabatelli M, Fionda L, Garibaldi M, Alfieri G, Lauletta A, Morino S, Salvetti M, Truini A, Antonini G (2022) Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation. Neurol Sci 43(2):1359–1364

Article  PubMed  Google Scholar 

Tozza S, Severi D, Palumbo G, Provitera V, Ruggiero L, Dubbioso R, Iodice R, Nolano M, Manganelli F (2022) Quantitative sensory testing in Late-Onset ATTRv presymptomatic subjects: a single center experience. Biomedicines 10(11):2877

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conceicao I, de Castro I, Diaz A, Castro J (2022) Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid 30(2):239–243

Article  PubMed  Google Scholar 

Leonardi L, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, Luigetti M, Romano A, Primiano G, Guglielmino V, Fionda L, Garibaldi M, Lauletta A, Rossini E, Tufano L, Ceccanti M, Esposito N, Falco P, di Pietro G, Truini A, Galosi E (2023) Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO). J Peripher Nerv Syst 28(3):390–397

Article  CAS  PubMed  Google Scholar 

England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF, Lauria G, Miller RG, Polydefkis M, Sumner AJ, N American Academy of N American Association of M Electrodiagnostic M American Academy of Physical, Rehabilitation (2009) Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review) Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R 1(1):5–13

Article  CAS  PubMed  Google Scholar 

Carroll AS, Razvi Y, O’Donnell L, Veleva E, Heslegrave A, Zetterberg H, Vucic S, Kiernan MC, Rossor AM, Gillmore JD, Reilly MM (2024) Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice. Amyloid 1–10

Kapoor M, Foiani M, Heslegrave A, Zetterberg H, Lunn MP, Malaspina A, Gillmore JD, Rossor AM, Reilly MM (2019) Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis. J Peripher Nerv Syst 24(4):314–319

Article  CAS  PubMed  Google Scholar 

Maia LF, Maceski A, Conceicao I, Obici L, Magalhaes R, Cortese A, Leppert D, Merlini G, Kuhle J, Saraiva MJ (2020) Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy. Amyloid 27(2):97–102

Article  CAS  PubMed  Google Scholar 

Louwsma J, Brunger AF, Bijzet J, Kroesen BJ, Roeloffzen WWH, Bischof A, Kuhle J, Drost G, Lange F, Kuks JBM, Gans ROB, Hazenberg BPC, Nienhuis HLA (2021) Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis. Amyloid 28(1):50–55

Article  CAS  PubMed  Google Scholar 

Ticau S, Sridharan GV, Tsour S, Cantley WL, Chan A, Gilbert JA, Erbe D, Aldinc E, Reilly MM, Adams D, Polydefkis M, Fitzgerald K, Vaishnaw A, Nioi P (2021) Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis. Neurology 96(3):e412–e422

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luigetti M, Di Paolantonio A, Guglielmino V, Romano A, Rossi S, Sabino A, Servidei S, Sabatelli M, Primiano G (2022) Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience. Neurol Sci 43(4):2845–2848

Article  PubMed  Google Scholar 

Loser V, Benkert P, Vicino A, Lim Dubois Ferriere P, Kuntzer T, Pasquier J, Maceski A, Kuhle J, Theaudin M (2023) Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience. J Peripher Nerv Syst 28(1):86–97

Article  CAS  PubMed  Google Scholar 

Romano A, Primiano G, Antonini G, Ceccanti M, Fenu S, Forcina F, Gentile L, Inghilleri M, Leonardi L, Manganelli F, Obici L, Sabino A, Sciarrone MA, Tozza S, Vitali F, Luigetti M (2024) Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? Eur J Neurol 31(1):e16070

Article  PubMed  Google Scholar 

Quan D, Obici L, Berk JL, Ando Y, Aldinc E, White MT, Adams D (2023) Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial. Amyloid 30(1):49–58

Article  PubMed  Google Scholar 

Galosi E, Falco P, Di Pietro G, Leone C, Esposito N, De Stefano G, Di Stefano G, Truini A (2022) The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN-SIQ) for identifying pure small fiber neuropathy. J Peripher Nerv Syst 27(4):283–290

Article  PubMed  PubMed Central  Google Scholar 

Devigili G, Rinaldo S, Lombardi R, Cazzato D, Marchi M, Salvi E, Eleopra R, Lauria G (2019) Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain 142(12):3728–3736

Article  PubMed  PubMed Central  Google Scholar 

Adams D, Ando Y, Beirão JM, Coelho T, Gertz MA, Gillmore JD, Hawkins PN, Lousada I, Suhr OB, Merlini G (2021) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol 268(6):2109–2122

Article  PubMed  Google Scholar 

Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL (2014) Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr 27(4):440–447

Article  PubMed  PubMed Central  Google Scholar 

Galosi E, Leonardi L, Falco P, Di Pietro G, Fasolino A, Esposito N, Leone C, Di Stefano G, Inghilleri M, Luigetti M, Giovanni A, Truini A (2022) Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings. Amyloid 1–8

Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio V, Vitale DF, Stancanelli A, Caporaso G, Liguori R, Wang N, Santoro L, Kennedy WR, Nolano M (2016) A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol 23(2):333–338